<DOC>
	<DOCNO>NCT01613794</DOCNO>
	<brief_summary>Epidemiological study show 2-3 fold increase long-term risk arterial cardiovascular disease venous thrombosis , predominant first year follow initial venous thrombosis . The result recent observational study show 40-50 % risk reduction first venous thrombosis occurrence use statin aspect promising . The result also somewhat surprising , mechanism behind effect unclear . Dyslipidemia may plausible explanation consider . However , dyslipidemia relate increase risk venous thrombosis , unlikely statin decrease venous thrombosis risk lipid lowering activity . Recent observation indicate coagulation activate initial formation atherosclerosis . Our hypothesis therefore coagulation profile person venous thrombosis improve use statin , ultimately lead less atherosclerosis : another well know property statin use .</brief_summary>
	<brief_title>Rosuvastatin Use Improve Coagulation Profile Patients With Venous Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Persons ( initial recurrent ) confirm symptomatic proximal deep vein thrombosis pulmonary embolism time period least 3 12 month allow stop , stop use &lt; 1 month anticoagulant treatment indicate treat physician Persons age 18 year Persons already use statin lipid lower drug , disallow concomitant medication ( erythromycin , HIV protease inhibitor , cyclosporine ) History statininduced myopathy , serious hypersensitivity reaction HMGCoA reductase inhibitor ( statin ) , include rosuvastatin Life expectancy le 6 month Pregnant woman woman childbearing potential willing use contraception Active liver kidney disease dysfunction muscle disorder Unstable medical psychological condition interferes study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Deep vein thrombosis</keyword>
	<keyword>Pulmonary embolism</keyword>
	<keyword>Rosuvastatin treatment</keyword>
	<keyword>Pharmacologic action</keyword>
</DOC>